rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-2-26
|
pubmed:abstractText |
Sleep apnoea syndrome (SAS) is common in acromegaly and both diseases are independently associated with hypertension and insulin resistance contributing to increased morbidity and mortality. Pituitary surgery remains the principal treatment modality in acromegaly. The aim of this study was to assess the prevalence and risk factors of SAS in acromegaly and to analyze the effect of transsphenoidal adenomectomy on SAS and cardiovascular risk factors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0804-4643
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321-9
|
pubmed:meshHeading |
pubmed-meshheading:17322492-Acromegaly,
pubmed-meshheading:17322492-Adult,
pubmed-meshheading:17322492-Aged,
pubmed-meshheading:17322492-Blood Glucose,
pubmed-meshheading:17322492-Cardiovascular Diseases,
pubmed-meshheading:17322492-Female,
pubmed-meshheading:17322492-Human Growth Hormone,
pubmed-meshheading:17322492-Humans,
pubmed-meshheading:17322492-Insulin-Like Growth Factor I,
pubmed-meshheading:17322492-Male,
pubmed-meshheading:17322492-Middle Aged,
pubmed-meshheading:17322492-Neurosurgical Procedures,
pubmed-meshheading:17322492-Prospective Studies,
pubmed-meshheading:17322492-Risk Factors,
pubmed-meshheading:17322492-Sleep,
pubmed-meshheading:17322492-Sleep Apnea Syndromes,
pubmed-meshheading:17322492-Sphenoid Bone,
pubmed-meshheading:17322492-Time Factors,
pubmed-meshheading:17322492-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Effect of transsphenoidal surgery on sleep apnoea in acromegaly.
|
pubmed:affiliation |
Division of Endocrinology and Diabetes, Department of Internal Medicine, Kantonsspital St Gallen, 9007 St Gallen, Switzerland. lisa.sze@bluewin.ch
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|